prikaz prve stranice dokumenta ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE
  Download
PDF 673.2 KB
master's thesis
ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE
Diplomski rad
Osijek: Josip Juraj Strossmayer University of Osijek, Faculty of Economics in Osijek, 2021. urn:nbn:hr:145:835219
Ivankovac, Ana
Josip Juraj Strossmayer University of Osijek
Faculty of Economics and Business in Osijek
Chair of Finance and Accounting

Institutional repository: EFOS REPOSITORY

Cite this document

Ivankovac, A. (2021). ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE : Diplomski rad (Master's thesis). Osijek: Josip Juraj Strossmayer University of Osijek, Faculty of Economics and Business in Osijek. Retrieved from https://urn.nsk.hr/urn:nbn:hr:145:835219

Ivankovac, Ana. "ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE : Diplomski rad." Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Economics and Business in Osijek, 2021. https://urn.nsk.hr/urn:nbn:hr:145:835219

Ivankovac, Ana. "ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE : Diplomski rad." Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Economics and Business in Osijek, 2021. https://urn.nsk.hr/urn:nbn:hr:145:835219

Ivankovac, A. (2021). 'ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE : Diplomski rad', Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Economics and Business in Osijek, accessed 27 June 2024, https://urn.nsk.hr/urn:nbn:hr:145:835219

Ivankovac A. ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE : Diplomski rad [Master's thesis]. Osijek: Josip Juraj Strossmayer University of Osijek, Faculty of Economics and Business in Osijek; 2021 [cited 2024 June 27] Available at: https://urn.nsk.hr/urn:nbn:hr:145:835219

A. Ivankovac, "ANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE : Diplomski rad", Master's thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Economics and Business in Osijek, Osijek, 2021. Available at: https://urn.nsk.hr/urn:nbn:hr:145:835219

Metadata
TitleANALIZA KRETANJA VRIJEDNOSTI DIONICA FARMACEUTSKIH TVRTKI OD 2017. DO 2020. GODINE : Diplomski rad
Title (english)ANALYSIS OF CHANGES IN THE VALUE OF SHARES OF PHARMACEUTICAL COMPANIES FROM 2017 TO 2020 : Graduate paper
AuthorAna Ivankovac
MentorDubravka Pekanov Starčević (mentor)
MentorAna Zrnić (komentor)
Committee memberIvo Mijoč (predsjednik povjerenstva)
Committee memberDubravka Pekanov Starčević (član povjerenstva)
Committee memberIvana Fosić (član povjerenstva)
GranterJosip Juraj Strossmayer University of Osijek
Faculty of Economics and Business in Osijek
(Chair of Finance and Accounting)
Osijek
Defense date and country2021-09-28, Croatia
Scientific / art field,
discipline and subdiscipline		SOCIAL SCIENCES
Economics
Finance
Abstract
Vrijednosne papire moguće je razlikovati s nekoliko aspekata. S funkcionalnog aspekta, oni se dijele na dužničke, vlasničke i hibridne te je takva podjela u podlozi ovoga rada. Dionice predstavljaju vlasničke vrijednosne papire koje vlasnicima donose određena prava. Razlikuju se redovne i povlaštene dionice, a mogu se izdavati kroz primarnu emisiju ili dokapitalizaciju. Postoji nekoliko oblika vrijednosti dionica, a to su nominalna, knjigovodstvena i tržišna vrijednost. Dionice se mogu vrednovati korištenjem različitih modela od kojih su najpoznatiji modeli vrijednosti za razdoblje držanja, model sadašnje vrijednosti dividendi i model tržišne kapitalizacije. U istraživačkom dijelu radu prikazana je analiza dionica tvrtki Pfizer, Johnson&Johnson te AstraZeneca u razdoblju od 2017. do 2020. godine. Kroz rad je prikazana kratka povijest promatranih tvrtki, a zatim su analizirane cijene dionica u promatranom razdoblju te postotna promjena istih. Nadalje, promatrana je veličina mjesečnog prometa dionicama analiziranih tvrtki. U analizi cijena i prometa, fokus je stavljen na odabrane, značajne promjene. Također, detaljnije je promatrana 2020. godina zbog pojave pandemije COVID-19 te njezinog utjecaja na promjene cijena i volumena trgovanja jer su dionice farmaceutskih kompanija u ovakvim uvjetima postale predmetom interesa za ulagače. Cilj je ovoga rada zaključiti o tome kako su se kretale promatrane dionice te u kolikom je postotku pandemija utjecala na vrijednost promatranih dionica.
Abstract (english)
Securities can be distinguished from several aspects. From the functional aspect, they are divided into debt, equity and hybrid, and such a division is the basis of this paper. Shares are equity securities that give owners certain rights. There are regular and preferred shares, and they can be issued through a primary issue or recapitalization. There are several forms of stock value, namely nominal, book value and market value. Shares can be valued using a variety of models, the most well-known of which are holding price models, the dividend present value model and the market capitalization model. The research part of the paper presents an analysis of the joint stock companies Pfizer, Johnson & Johnson and AstraZeneca in the period from 2017 to 2020. The paper presents a short history of the observed companies, and then analyzes the share prices in the observed period and their percentage change. Furthermore, the size of the monthly turnover of shares of the analyzed companies was observed. In price and turnover analysis, the focus is on selected, significant changes. Also, 2020 is observed in more detail due to the outbreak of the COVID-19 pandemic and its impact on changes in price and trading volume, because the shares of pharmaceutical companies in such conditions have become the subject of interest for investment. The aim of this paper is to conclude about how the observed shares moved and in what percentage the pandemic affected the value of the observed shares.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:145:835219
Study programmeTitle: Financial Management
Study programme type: university
Study level: graduate
Academic / professional title: magistar/magistra ekonomije (magistar/magistra ekonomije)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2022-05-05 10:09:42